Development of Vaccines against Bacterial Infections

Dear Colleagues,

The Special Issue titled "Development of Vaccines against Bacterial Infections" aims at providing a comprehensive overview of the current state of research in the field of vaccine development against bacterial infections. Bacterial infections continue to pose significant challenges to public health worldwide, with the emergence of antibiotic resistance. The re-emergence of vaccine-preventable diseases during the post-antibiotic era highlights the urgent need for novel vaccine strategies. This Special Issue will cover a wide range of topics related to bacterial vaccine development, including advances in vaccine design, mechanisms of bacterial pathogenesis, the preclinical and clinical evaluation of vaccine candidates, the use of bacteria in vaccine development, and strategies for vaccine delivery and formulation. Contributions from leading researchers and experts in the field will provide insights into the latest scientific advancements, challenges, and opportunities in the development of vaccines against bacterial infections. The goal of this Special Issue is to foster collaboration and knowledge exchange among scientists, clinicians, policymakers, and industry stakeholders to accelerate the development of effective vaccines that can mitigate the burden of bacterial diseases and improve global health outcomes.

Prof. Dr. John Hwa Lee
Prof. Dr. Amal Senevirathne
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• novel vaccine formulations
• bacterial pathogenesis mechanisms
• immunogenicity assessment
• vaccine efficacy studies
• next-generation vaccine platforms
• targeted antigen design
• novel adjuvants
• vaccine clinical trials
• vaccine delivery systems
• vaccine cross-protection